
Metabolic abnormalities in human immunodeficiency virus patients with protease inhibitor-based therapy
Author(s) -
Tumnyak Ete,
Salam Ranabir,
Narmada Thongam,
Ningthoujam Biplab,
Narendra Rajkumar,
Thongam Bhimo
Publication year - 2014
Publication title -
indian journal of sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 1998-3816
pISSN - 0253-7184
DOI - 10.4103/0253-7184.142399
Subject(s) - medicine , regimen , diabetes mellitus , ritonavir , waist , blood pressure , metabolic syndrome , lipodystrophy , gastroenterology , endocrinology , viral load , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , body mass index
Several studies have reported metabolic abnormalities in patients taking protease inhibitor (PI) based therapy from several parts of the world. But there is no prospective study in India after switching from PI sparing regimen to PI based regimen.